Skip to content

Daily aciclovir slows HIV disease progression and reduces viral load

Image by Greta Hughson (aidsmap.com)

HIV damages B-cells as well as T-cells: new treatment targets identified

Rilpivirine (Edurant) approved in United States

Gold-based drug shows promise in clearing HIV reservoir in monkey study

Once-daily nevirapine approved in United States

Transmissible gene therapy treatment proposed for HIV to curb epidemic

Once-daily raltegravir found inferior to twice-daily dosing

Attachment inhibitor BMS-663068 potent and well-tolerated in early study